Clinical Trial: Everolimus and LongActing Octreotide Trial in Polycystic Livers

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Everolimus Added to Long Acting Octreotide as a Volume Reducing Treatment of Polycystic Livers

Brief Summary: The aim of this study is to reduce polycystic liver volume by treating with octreotide, whether or not combined with everolimus; to assess whether combination therapy of everolimus and octreotide gives a bigger reduction of polycystic liver volume than octreotide monotherapy.